Romain Hardet

699 total citations
14 papers, 452 citations indexed

About

Romain Hardet is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Romain Hardet has authored 14 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Romain Hardet's work include Virus-based gene therapy research (10 papers), CAR-T cell therapy research (7 papers) and Adenosine and Purinergic Signaling (4 papers). Romain Hardet is often cited by papers focused on Virus-based gene therapy research (10 papers), CAR-T cell therapy research (7 papers) and Adenosine and Purinergic Signaling (4 papers). Romain Hardet collaborates with scholars based in France, Germany and United States. Romain Hardet's co-authors include Helena Costa Verdera, Giuseppe Ronzitti, Fanny Collaud, Solenne Marmier, Christian Leborgne, Federico Mingozzi, P. Véron, Klaudia Kuranda, Séverine Charles and Laetitia van Wittenberghe and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Romain Hardet

14 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Romain Hardet France 9 297 267 148 63 57 14 452
Marcelo Simon Sola France 8 428 1.4× 406 1.5× 134 0.9× 80 1.3× 97 1.7× 11 621
Geoffrey D. Keeler United States 9 217 0.7× 208 0.8× 100 0.7× 46 0.7× 41 0.7× 14 387
Elisa Masat Italy 10 216 0.7× 233 0.9× 86 0.6× 52 0.8× 100 1.8× 12 465
Greg M. Podsakoff United States 8 314 1.1× 266 1.0× 97 0.7× 39 0.6× 44 0.8× 13 409
Federico Mingozzi France 6 198 0.7× 232 0.9× 79 0.5× 36 0.6× 53 0.9× 6 352
Kathleen Meyer United States 11 219 0.7× 313 1.2× 73 0.5× 21 0.3× 64 1.1× 23 469
Guo-jie Ye United States 5 251 0.8× 257 1.0× 88 0.6× 40 0.6× 44 0.8× 9 362
Alex Tai United States 6 450 1.5× 400 1.5× 152 1.0× 105 1.7× 65 1.1× 9 542
Kazuhiro Masui Japan 11 250 0.8× 274 1.0× 140 0.9× 60 1.0× 176 3.1× 17 617
Nicole C. Hasbrouck United States 5 550 1.9× 470 1.8× 228 1.5× 87 1.4× 72 1.3× 8 677

Countries citing papers authored by Romain Hardet

Since Specialization
Citations

This map shows the geographic impact of Romain Hardet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romain Hardet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romain Hardet more than expected).

Fields of papers citing papers by Romain Hardet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romain Hardet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romain Hardet. The network helps show where Romain Hardet may publish in the future.

Co-authorship network of co-authors of Romain Hardet

This figure shows the co-authorship network connecting the top 25 collaborators of Romain Hardet. A scholar is included among the top collaborators of Romain Hardet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romain Hardet. Romain Hardet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hardet, Romain, et al.. (2023). Capsid-modified adeno-associated virus vectors as novel vaccine platform for cancer immunotherapy. Molecular Therapy — Methods & Clinical Development. 29. 238–253. 8 indexed citations
2.
Hardet, Romain, Andreas Schneider, Florian W. R. Vondran, et al.. (2023). Modifying immune responses to adeno-associated virus vectors by capsid engineering. Molecular Therapy — Methods & Clinical Development. 30. 576–592. 17 indexed citations
3.
Danquah, Welbeck, Romain Hardet, Friedrich Haag, et al.. (2022). Development of Antibody and Nanobody Tools for P2X7. Methods in molecular biology. 2510. 99–127. 8 indexed citations
4.
Hardet, Romain, Catalina Abad, Stephan Menzel, et al.. (2022). Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models in vivo. Frontiers in Immunology. 13. 1012534–1012534. 7 indexed citations
5.
Hardet, Romain, et al.. (2021). A Methodological Approach Using rAAV Vectors Encoding Nanobody-Based Biologics to Evaluate ARTC2.2 and P2X7 In Vivo. Frontiers in Immunology. 12. 704408–704408. 10 indexed citations
6.
Abad, Catalina, Romain Hardet, Anna Marei Eichhoff, et al.. (2020). Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano). Frontiers in Oncology. 10. 1699–1699. 13 indexed citations
7.
Long, Brian, P. Véron, Klaudia Kuranda, et al.. (2020). Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A. Molecular Therapy. 29(2). 597–610. 54 indexed citations
8.
Poupiot, Jérôme, Helena Costa Verdera, Romain Hardet, et al.. (2019). Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle. Molecular Therapy — Methods & Clinical Development. 15. 83–100. 19 indexed citations
9.
Boisgérault, Florence, Romain Hardet, Solenne Marmier, et al.. (2018). Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications. 9(1). 4098–4098. 203 indexed citations
10.
Kuranda, Klaudia, Christian Leborgne, Romain Hardet, et al.. (2018). Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. Journal of Clinical Investigation. 128(12). 5267–5279. 78 indexed citations
11.
12.
Colella, Pasqualina, Francesco Puzzo, Maria Grazia Biferi, et al.. (2017). Whole-body rescue of Pompe disease with AAV liver delivery of engineered secretable GAA transgenes. Neuromuscular Disorders. 27. S246–S246. 1 indexed citations
13.
Hardet, Romain, Benjamin Chevalier, Gaëtan Riou, et al.. (2015). Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector. Molecular Therapy. 24(1). 87–95. 16 indexed citations
14.
Lorain, Stéphanie, Pascal Chappert, Romain Hardet, et al.. (2014). Intrinsic Transgene Immunogenicity Gears CD8+ T-cell Priming After rAAV-Mediated Muscle Gene Transfer. Molecular Therapy. 23(4). 697–706. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcelo Simon Sola Breakdown of academic impact, for papers by Geoffrey D. Keeler Breakdown of academic impact, for papers by Elisa Masat Breakdown of academic impact, for papers by Greg M. Podsakoff Breakdown of academic impact, for papers by Federico Mingozzi Breakdown of academic impact, for papers by Kathleen Meyer Breakdown of academic impact, for papers by Guo-jie Ye Breakdown of academic impact, for papers by Alex Tai Breakdown of academic impact, for papers by Kazuhiro Masui Breakdown of academic impact, for papers by Nicole C. Hasbrouck
Rankless by CCL
2026